Skip to contentC
Cryo Cell International Inc
C
CCELCryo Cell International Inc Q4 2021 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$7.32M$7.32Mderived−3.0% vs Q4 2020 Net Income-$637.19K-$637.19KderivedN/M vs Q4 2020 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cryo Cell International Inc · CIK 862692 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$808,434N/M Operating Cash Flowderived$1,667,475−44.0% Free Cash Flowderived$1,387,482−52.6% Margins · derivedOperating margin-11.1%−40.0 pt vs Q4 2020
Net margin-8.7%−24.6 pt vs Q4 2020
ended Nov 30, 2021 · filed Feb 22, 2022 · 84 d after period end